Results 81 to 90 of about 6,002 (227)

Continuing Professional Development—Radiation Therapy

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 174-174, March 2025.
wiley   +1 more source

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis [PDF]

, 2013
N.E. Verstegen, J. Wolter Oosterhuis, David A. Palma, George Rodrigues, Frank J. Lagerwaard, A. van der Elst, R. Mollema, Willem F. van Tets, A. Warner, Hanneke Joosten, M.I. Amir, Cornelis J.A. Haasbeek, Egbert F. Smit, Ben J. Slotman, Suresh Senan   +14 more
openalex   +1 more source

Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy

Journal of Medical Physics, 2017
Aim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT ...
Prabhakar Ramachandran, Abdulrahman Tajaldeen, David Taylor, Derrick Wanigaratne, Karl Roozen, Moshi Geso   +5 more
doaj   +1 more source

Fondacija Sabre [PDF]

Kemija u industriji : časopis kemičara i tehnologa Hrvatske, 2001
Fondacija Sabre povezuje se sa neprofitnim organizacijama u zemljama sa kojima surađuje, od kojih neke nose ime same Fondacije. Europske podružnice članice su Sabre Europe sa sjedištem u Bruxellesu koja je osnovana 1993. godine u cilju bolje suradnje.
openaire   +1 more source

Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases – clinical results [PDF]

, 2012
Judit Boda‐Heggemann, Dietmar Dinter, Christel Weiß, Anian Frauenfeld, Kerstin Siebenlist, Ulrike Attenberger, Martine Ottstadt, David Schneider, Ralf‐Dieter Hofheinz, Frederik Wenz, Frank Lohr   +10 more
openalex   +1 more source

SABR for oligometastatic renal cell carcinoma

Clinical and Translational Radiation Oncology
Stereotactic ablative body radiotherapy (SABR) aims to accurately deliver a higher than conventional dose of radiotherapy to a well-defined target tumour incorporating advanced immobilisation and imaging techniques.
Chang David, Ali Muhammad, Udovicich Cristian, Tran Ben, Azad Arun, Au Lewis, Spain Lavinia, Perera Marlon, Siva Shankar   +8 more
doaj   +1 more source

Du sabre

, 2014
Fruit de recherches approfondies sur l'histoire de la presse de l'époque Meiji, Du sabre à la plume donne un éclairage nouveau sur cette époque située entre le milieu du xixe siècle et le début du xxe, en donnant accès à des récits autobiographiques originaux, inédits en langue occidentale.
Suehiro Tetchô, Tokutomi Sohô, Fukuchi Ôchi, Christiane Séguy   +3 more
openaire   +1 more source

MENEMUKAN MAQASHID AL-SYARI'AH: AL-SABR WA AL-TAQSIM, THARD DAN TANQIH AL-MANATH

, 2022
Nailul Rahmi
openalex   +2 more sources

Target volatility option pricing in lognormal fractional SABR model [PDF]

, 2018
Elisa Alòs, Rupak Chatterjee, Sebastian F. Tudor, Tai‐Ho Wang   +3 more
openalex   +1 more source

Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma

Clinical and Translational Radiation Oncology
Background and purpose: Stereotactic ablative body radiotherapy (SABR) is an effective treatment for localized renal cell carcinoma (RCC). However, the role of primary site SABR for locally recurrent or metastatic RCC is unclear. Here, we report outcomes
Daniel Huang, Connor Lynch, Lucas M. Serra, Randy F. Sweis, Paul J. Chang, Walter M. Stadler, Russell Z. Szmulewitz, Peter H. O’Donnell, Abhinav Sidana, Scott E. Eggener, Arieh L. Shalhav, Stanley L. Liauw, Sean P. Pitroda   +12 more
doaj   +1 more source